Editorial: Ozone in medicine: Biochemical background, physiological modulation and clinical applications

Bernardino Clavo; Emma Borrelli

doi:10.3389/fphys.2023.1112860

Editorial: Ozone in medicine: Biochemical background, physiological modulation and clinical applications

Front Physiol. 2023 Feb 6:14:1112860. doi: 10.3389/fphys.2023.1112860. eCollection 2023.

Authors

Bernardino Clavo^{1

2

3}, Emma Borrelli^{4

5}

Affiliations

¹ Research Unit, Chronic Pain Unit, and Radiation Oncology Department, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas, Spain.
² Fundación Canaria Instituto de Investigación Sanitaria de Canarias (FIISC), Las Palmas, Spain.
³ Instituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias de la Universidad de La Laguna, Tenerife, Spain.
⁴ Department of Medical Biotechnologies, University of Siena, Siena, Italy.
⁵ Postgraduate Course on Oxygen Ozone Therapy, University of Siena, Siena, Italy.

No abstract available

Keywords: Nrf2; bronchial asthma; chemotherapy-induced peripheral neuropathy (CIPN); oxidative stress; ozone therapy; pain; rheumathoid arthritis.

Publication types

Editorial

Grants and funding

The randomized controlled trial NCT04299893 was partially supported by a grant (PI 19/00458) from the Instituto de Salud Carlos III (Spanish Ministry of Science and Innovation, Madrid, Spain and European Regional Development Fund-ERDF), a grant (016/2019) from the Fundación DISA (Las Palmas, Spain), and a grant (BF1-19-03) from the Fundación Española del Dolor (Spanish Pain Foundation, Madrid, Spain).